Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of topical omiganan for external genital warts
NL-OMON43535Phase 2Active, not recruiting
- Sponsor
- Biofrontera
- Start
- Jun 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of omiganan in anogenital warts, human papillomavirus infection, sponsored by Biofrontera. Started Jun 2016; status: active, not recruiting.
02
Drugs
omiganan
03
Conditions
anogenital wartshuman papillomavirus infection
Beyond the preview
Go deeper on NL-OMON43535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43535.